{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:12:38Z","timestamp":1794978758176,"version":"4.9.1"},"reference-count":27,"publisher":"Frontiers Media SA","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2344,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1111\/j.1432-2277.2008.00824.x","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T09:55:39Z","timestamp":1232618139000},"page":"475-481","source":"Crossref","is-referenced-by-count":36,"title":["Kidney transplantation in patients with Fabry disease"],"prefix":"10.3389","volume":"22","author":[{"given":"Markus","family":"Cybulla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin Nanette","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schwarting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaelle","family":"DiVito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Feriozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gere","family":"Sunder-Plassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the European FOS Investigators Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","reference":[{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14712598.2.3.325","article-title":"Advances in the management of Anderson-Fabry disease: enzyme replacement therapy","volume":"2","author":"Pastores","year":"2002","journal-title":"Expert Opin Biol Ther"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB2","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1053\/j.ajkd.2005.01.036","article-title":"Chronic renal failure and proteinuria in adulthood: Fabry disease predominantly affecting the kidneys","volume":"45","author":"Cybulla","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"issue":"Suppl 2","key":"10.1111\/j.1432-2277.2008.00824.x-BIB4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1012447102358","article-title":"Natural history of Fabry disease in affected males and obligate carrier females","volume":"24","author":"MacDermot","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01986897","article-title":"Ein Beitrag Zur Kenntnis der Purpura haemorrhagica nodularis (Purpura papulosa hemorrhagica Hebrae)","volume":"43","author":"Fabry","year":"1898","journal-title":"Arch Derm Syph"},{"issue":"Suppl 2","key":"10.1111\/j.1432-2277.2008.00824.x-BIB6","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1097\/01.ASN.0000015235.57104.A1","article-title":"Anderson-Fabry disease: its place among other genetic causes of renal disease","volume":"13","author":"Grunfeld","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ki.1978.32","article-title":"Early renal changes in hemizygous and heterozygous patients with Fabry disease","volume":"13","author":"Gubler","year":"1978","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1111\/j.1432-2277.2008.00824.x-BIB8","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1097\/01.ASN.0000016683.73778.78","article-title":"Natural history and treatment of renal involvement in Fabry disease","volume":"13","author":"Branton","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2362.2004.01424.x","article-title":"Fabry disease: overall effects of agalsidase alfa treatment","volume":"34","author":"Beck","year":"2004","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 1","key":"10.1111\/j.1432-2277.2008.00824.x-BIB10","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"2","year":"2002","unstructured":"10.K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 2(Suppl 1): S1.","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy","volume":"65","author":"Whybra","year":"2004","journal-title":"Clin Genet"},{"issue":"Suppl 7","key":"10.1111\/j.1432-2277.2008.00824.x-BIB12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ndt\/11.supp7.4","article-title":"Report on management of renal failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry","volume":"11","author":"Tsakiris","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB13","first-page":"1055","article-title":"Outcome of end-stage renal disease in patients with rare causes of renal failure. I. Inherited and metabolic disorders","volume":"73","author":"Nissenson","year":"1989","journal-title":"Q J Med"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB14","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/00007890-200006150-00020","article-title":"Excellent outcome of renal transplantation in patients with Fabry disease","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00007890-198410000-00001","article-title":"Transplantation in relation to the treatment of inherited disease","volume":"38","author":"Groth","year":"1984","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0272-6386(12)80172-7","article-title":"Recurrent diseases in the kidney transplant","volume":"24","author":"Ramos","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB17","first-page":"287","article-title":"Recurrence of Fabry disease in a renal allograft 14\u2003years after transplantation","volume":"10","author":"Gantenbein","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB18","first-page":"206","article-title":"Renal biopsy in Fabry disease eight years after successful renal transplantation","volume":"27","author":"Friedlaender","year":"1987","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000167493","article-title":"Involvement of renal allograft by Fabry disease","volume":"7","author":"Popli","year":"1987","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A - replacement therapy in Fabry disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB21","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1742-1241.2006.01237.x","article-title":"Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature","volume":"61","author":"Lidove","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB23","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1523-1755.2004.00514.x","article-title":"Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study","volume":"65","author":"Mignani","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB24","first-page":"77","article-title":"Enzyme replacement therapy and renal function in 201 patients with Fabry disease","volume":"66","author":"Schwarting","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfi152","article-title":"Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting","volume":"21","author":"Schiffmann","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase beta therapy for advanced Fabry disease","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1432-2277.2008.00824.x-BIB27","first-page":"395","volume-title":"Fabry disease - Perspectives from 5\u2003years of FOS","author":"Barbey","year":"2006"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2008.00824.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2008.00824.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T13:38:53Z","timestamp":1641044333000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2008.00824.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00824.x","relation":{},"ISSN":["0934-0874","1432-2277"],"issn-type":[{"value":"0934-0874","type":"print"},{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}